Xingfeng He

机构：Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center · ORCID：0000-0003-2035-2516

发表论文 13 篇 · 总被引 610 次 · h-index 8

代表论文

• LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma (2022 · Journal of Hematology & Oncology · 被引 249)
• Patient‐Derived Organoids from Colorectal Cancer with Paired Liver Metastasis Reveal Tumor Heterogeneity and Predict Response to Chemotherapy (2022 · Advanced Science · 被引 196)
• Assay establishment and validation of a high-throughput organoid-based drug screening platform (2022 · Stem Cell Research & Therapy · 被引 54)
• Patient-derived organoids as a platform for drug screening in metastatic colorectal cancer (2023 · Frontiers in Bioengineering and Biotechnology · 被引 50)
• Personalized circulating tumor DNA monitoring improves recurrence surveillance and management after curative resection of colorectal liver metastases: a prospective cohort study (2024 · International Journal of Surgery · 被引 22)
• SNHG17 alters anaerobic glycolysis by resetting phosphorylation modification of PGK1 to foster pro-tumor macrophage formation in pancreatic ductal adenocarcinoma (2023 · Journal of Experimental & Clinical Cancer Research · 被引 20)